A national survey reveals that nearly all oncologists and ID specialists are highly concerned about the negative impact of infection on treatment outcomes in chemotherapy patients. Infections among chemotherapy patients are common, with one in four patients experiencing an infection in the last 12 months.
A study of long-term Enbrel use found a consistent safety profile in patients with moderate-to-severe juvenile rheumatoid arthritis. Sixty-one percent of patients completed four years of therapy, and 38% reached eight years without significant adverse effects.
A survey of 1,142 patients with chronic moderate to severe plaque psoriasis found that nearly 40% are not receiving treatment. The study also showed that those with severe psoriasis are more likely to have a lower household income.